SUNA 2008 - Solifenacin Treatment of Patients with Severe Overactive Bladder Symptoms: Effects on Diary-Based and Patient-Reported Outcomes - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - This was a post hoc analysis of solifenacin Efficacy and Safety in Patients with Urgency Study (VENUS) to determine patients with severe OAB symptoms at baseline.
Login to read more...
|
SUNA 2008 - Decreasing Catheter Associated UTIs (CAUTIs): Our Journey - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - This descriptive study reported on the relatively high number of CAUTIs in a 35 bed urology, medical-surgery unit.
Login to read more...
|
SUNA 2008 - Oxybutynin Chloride Topical Gel for Overactive Bladder: Effects of Showering, Sunscreen and Person-to-Person Transference - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - Three open-label randomized studies were conducted in healthy men and women to investigate the effects of showering, sunscreen, and person-to-person transfer of oxybutynin chloride topical gel (OTG).
Login to read more...
|
SUNA 2008 - Recovery of Sexual Function Following Radical Prostatectomy: Self-Reports at Postoperative Year One - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - This was a pilot randomized clinical trial (n=44) in an academic health science center that was to evaluate three approaches to pelvic floor muscle training (PFMT) following radical prostatectomy.
Login to read more...
|
SUNA 2008 - Darifenacin's Effectiveness in OAB Wet Patients as Measured by Dry Days - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - This analysis set forth to determine the onset and number of consecutive dry days and reductions of UI episodes (IEs) provided by darifenacin, using pooled data from 3 phase III studies (multicenter, randomized, double-blind, placebo-controlled 12-week studies with darifenacin of fixed-doses of 7.5 and 15 mg once daily).
Login to read more...
|
SUNA 2008 - Efficacy and Safety of Silodosin for the Treatment of Signs and Symptoms of BPH: Pooled Results of Two Randomized, Placebo-Controlled Studies and Results of a 9-Month Open-Label Extension Study - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - Silodosin is an alpha blocker which was recently approved by the FDA for men with BPH.
Login to read more...
|
SUNA 2008 - Use of Percutaneous Tibial Nerve Stimulation (PTNS) to Treat Overactive Bladder - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - A retrospective chart review of 23 patients (22 women and 1 male) who completed 12 weekly, 20 minute treatments.
Login to read more...
|
SUNA 2008 - Exploring Caffeine Intake in Women with OAB and Mental Health Disease - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - Higher caffeine consumption can contribute to OAB.
Login to read more...
|
SUNA 2008 - Pelvic Floor Muscle Retraining: Quantitative, Experimental, Randomized Pilot Study - Highlight
Tuesday, 21 October 2008
PHILADELPHIA, PA, USA (UroToday.com) - A descriptive study compared active transvaginal stimulation (TVS) versus passive electrical stimulation (ES) in 66 female volunteers.
Login to read more...
|
Conference Coverage 
